Abstract
The development of vaccines to prevent human and animal diseases has been a challenging task for generations of physicians, microbiologists and biochemists. Jenner’s fundamental publication on inoculation of susceptible people with cowpox virus was the first documented evidence for the efficacy of vaccination (Jenner 1798). Since then, a number of vaccines against a variety of viral and bacterial infections have been used in man and animals. Other vaccines have been developed to protect against parasitic infections. More recently, experimental immunotherapies against cancers have been developed which utilise conjugate vaccine technology (for review see Bittle and Murphy 1989). Although only a few diseases have been totally eliminated through vaccination, the availability of vaccines has led to dramatic reductions in morbidity and mortality. However, there are still many infectious diseases against which vaccines need to be developed (for reviews see Bell and Torrigiani 1987; Mizrahi 1990). Moreover, problems remain regarding the efficacy of some currently available vaccines in the general population. The development of new carrier materials, capable of enhancing immunogenicity and long term immunological memory, is seen as an important contribution toward solving the remaining problems in vaccination.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Altman A, Dixon FJ (1989) Immunomodifiers in vaccines. In: Bittle JL, Murphy FL (eds) Vaccine biotechnology. Advances in veterinary science and comparative medicine, vol 33. Academic Press, San Diego, pp 301–343
Altman E, Brisson J-R, Messner P, Sleytr UB (1990) Chemical characterisation of the regularly arranged surface layer glycoprotein of Clostridium thermosaccharolyticum Dl20–70. Eur J Biochem 188:73–82
Altman E, Brisson J-R, Gagné S, Kolbe J, Messner P, Sleytr UB (1991a) Structure of the glycan chain from the surface layer glycoprotein of Clostridium thermohydrosulfuricum L77–66. Glycoconjugate J 8:242
Altman E, Brisson J-R, Messner P, Sleytr UB (1991b) Chemical characterisation of the regularly arranged surface layer glycoprotein of Bacillus alvei CCM 2051. Biochem Cell Biol 69:72–78
Anderson P (1983) Antibody responses to H. influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infect Immun 39:233–238
Avery OT, Goebel WF (1929) Chemo-immunological studies on conjugated carbohydrate proteins. II Immunological specificity of synthetic sugar-protein antigens. J Exp Med 50:533–550
Bell R, Torrigiani G (eds) (1987) Towards better carbohydrate vaccines. J Wiley and Sons. Chichester
Bittle JL, Murphy FL (eds) (1989) Vaccine biotechnology. Advances in veterinary science and comparative medicine, vol 33. Academic Press, San Diego
Bixler GS Jr, Pillai S (1989) The cellular basis of the immune response to conjugate vaccines. In: Cruse JM, Lewis RE Jr (eds) Conjugate vaccines. Contributions to microbiology and immunology, vol 10. Karger, Basel, pp 18–47
Christian R, Schulz G, Unger FM, Messner P, Küpcü Z, Sleytr UB (1986) Structure of a rhamnan from the surface layer glycoprotein of Bacillus stearothermophilus strain NRS 2004/3a. Carbohydr Res 150:265–272
Christian R, Messner P, Weiner C, Sleytr UB, Schulz G (1988) Structure of a glycan form the surfacelayer glycoprotein of Clostridium thermohydrosulfuricum strain L111–69. Carbohydr Res 176:160–163
Cruse JM, Lewis RE Jr (1989) Contemporary trends in conjugate vaccine development. In: Cruse JM, Lewis RE Jr (eds) Conjugate vaccines. Contributions to microbiology and immunology, vol 10. Karger, Basel, pp 1–10
Dick WE, Burret M (1989) Glycoconjugates of bacterial carbohydrate antigens. A survey and consideration of design and preparation factors. In: Cruse JM, Lewis RE Jr (eds) Conjugate vaccines. Contributions to microbiology and immunology. vol 10. Karger. Basel. pp 48–114
Goebel WF, Avery OT (1929) Chemo-immunological studies on conjugated carbohydrate-proteins. I. The synthesis of p-aminophenol ß-glucoside, p-aminophenol ß-galactoside, and their coupling with serum globulin. J Exp Med 50:521–531
Gordon LK (1984) Characterisation of a hapten-carrier conjugate vaccine: H. influenzae-diphtheria conjugate vaccine. In: Chanock RM, Lerner RA (eds) Vaccines ’84. Modern approaches to vaccines. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 393–396
Hakomori S, Kannagi R (1986) Carbohydrate antigens in higher animals. In: Weir DM, Herzenberg LA, Blackwell C, Herzenberg LA (eds) Handbook of experimental immunology, 4th ed, vol 1, Immunochemistry. Blackwell, Oxford, pp 9.1–9.39
Heidelberger M, Avery OT (1923) The soluble specific substance of Pneumococcus I. J Exp Med 38:73–79
Jenner E (1798) An inquiry into the uses and effects of the variolea vaccine. Sampson Low. London
Kandler O (1982) Cell wall structures and their phylogenic implications. Zbl Bakt Hlyg I Abt Orig C 3:149–160
Kenne L, Lindberg B (1983) Bacterial polysaccharides. In: Aspinall GO (ed) The Polysaccharides, vol 2. Academic Press, New York, pp 287–363
König H (1988) Archaeobacterial cell envelopes. Can J Microbiol 34:395–406
Kornfeld R, Kornfeld S (1980) Structure of glycoproteins and their oligosaccharide units. In: Lennarz WJ (ed) The biochemistry of glycoproteins and proteoglycans. Plenum Press. New York pp 1–34
Koval SF (1988) Paracrystalline protein surface arrays on bacteria. Can J Microbiol 34:407–414
Küpcü Z, MÑrz L, Messner P, Sleytr UB (1984) Evidence for the glycoprotein nature of the crystalline cell wall surface layer of Bacillus stearothermophilus strain NRS 2004/3a. FEBS Lett 173:185–190
Lechner J, Wieland F (1989) Structure and biosynthesis of prokaryotic glycoproteins. Annu Rev Biochem 58:173–194
Lemieux RU (1987) Applications of synthetic complex oligosaccharides to areas of molecular biology. In: Bell R, Torrigiani G (eds) Towards better carbohydrate vaccines. J Wiley and Sons, Chichester, pp 41–58
Malcolm AJ, Shipman RC, Levy JG (1984) A monoclonal antibody to myelogenous leukemia: isolation and characterisation. Exper Haematology 12:539–547
Messner P, Sleytr UB (1988a) Asparaginyl-rhamnose: a novel type of protein-carbohydrate linkage in an eubacterial surface-layer glycoprotein. FEBS Lett 228:317–320
Messner P, Sleytr UB (1988b) Isolation and purification of S-layers from Gram-positive and Gramnegative bacteria. In: Hancock IC, Poxton IR (eds) Bacterial cell-surface techniques. J Wiley and Sons, Chichester, pp 97–104
Messner P, Sleytr UB (1991) Bacterial surface layer glycoproteins. Glycobiology 1:545–551
Messner P, Sleytr UB (1992) Crystalline bacterial cell-surface layers. In: Rose AH, Tempest DW (eds) Advances in microbial physiology, vol 33. Academic Press, London, in press
Messner P, Sleytr UB, Christian R, Schulz G, Unger FM (1987) Isolation and structure determination of a diacetamidodideoxyuronic acid-containing glycan from the S-layer glycoprotein of Bacillus stearothermophilus NRS 2004/3a. Carbohydr Res 168:211–218
Messner P, Bock K, Christian R, Schulz G, Sleytr UB (1990) Characterisation of the surface layer glycoprotein of Clostridium symbiosum HB25. J Bacteriol 172:2576–2583
Messner P, Küpcü S, Sara M, Pum D, Sleytr UB (1991) Characterisation and biotechnological application of eubacterial glycoproteins. In: Conradt HS (ed) Protein glycosylation: cellular, biotechnological and analytical Aspects. GBF Monographs, vol 15. VCH Publishers, Weinheim, pp 111–116
Mizrahi A (ed) (1990) Bacterial vaccines. Advances in biotechnological processes, vol 13. Wiley-Liss, New York
Nusser E, Hartmann E, Allmeier H, König H, Paul G, Stetter KO (1988) A glycoprotein surface layer covers the pseudomurein sacculus of the extreme thermophile Methanothermus fervidus. In: Sleytr UB, Messner P, Pum D, Sara M (eds) Crystalline bacterial cell-surface layers. Springer, Berlin pp 21–25
Sára M, Sleytr UB (1989) Use of regularly structured bacterial cell envelope layers as matrix for the immobilisation of macromolecules. Appl Microbiol Biotechnol 30:184–189
Sara M, Küpcü S, Sleytr UB (1989) Localisation of the carbohydrate residue of the S-layer glycoprotein from Clostridium thermohydrosulfuricum L111–69. Arch Microbiol 151:416–420
Schneerson R, Barrera O, Sutton A, Robbins JB (1980) Preparation, characterisation and immunogenicity of H. influenzae type B polysaccharide-protein conjugates. J Exp Med 152:361–376
Sela M (1987) The choice of carrier. In: Amon R (ed) Synthetic vaccines, vol I. CRC Press, Boca Raton, Fla, pp 83–92
Sleytr UB (1978) Regular arrays of macromolecules on bacterial cell walls: structure, chemistry, assembly, and function. Int Rev Cytol 53:1–64
Sleytr UB, Messner P (1983) Crystalline surface layers on bacteria. Annu Rev Microbiol 37:311–339
Sleytr UB, Messner P (1988) Crystalline surface layers on procaryotes. J Bacteriol 170:2891–2897
Sleytr UB, Mundt W, Messner P (1987) Pharmazeutische Struktur. German patent application, No P 37 27 987.4, 21.8.1987
Sleytr UB, Mundt W, Messner P, Smith RH, Unger FM (1991) Immunogenic compositions containing ordered carriers. US patent, No 5,043,1 58
Smit J (1987) Protein surface layers of bacteria. In: Inouye M (ed) Bacterial outer membranes as model systems. J Wiley and Sons, New York, pp 343–376
Smith RH, Ziola B (1986) Cyclophosphamide and dimethyl-dioctadecyl ammonium bromide immunopotentiate the delayed-type hypersensitivity response to inactivated enveloped viruses. Immunology 58:245–250
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag London
About this chapter
Cite this chapter
Malcolm, A.J., Messner, P., Sleytr, U.B., Smith, R.H., Unger, F.M. (1993). Crystalline Bacterial Cell Surface Layers (S-Layers) as Combined Carrier/Adjuvants for Conjugate Vaccines. In: Sleytr, U.B., Messner, P., Pum, D., Sára, M. (eds) Immobilised Macromolecules: Application Potentials. Springer Series in Applied Biology. Springer, London. https://doi.org/10.1007/978-1-4471-3479-4_13
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3479-4_13
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3481-7
Online ISBN: 978-1-4471-3479-4
eBook Packages: Springer Book Archive